Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LYPRESSIN: 64 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
64
Total FAERS Reports
63 (98.4%)
Deaths Reported
54
Hospitalizations
64
As Primary/Secondary Suspect
44
Life-Threatening
57
Disabilities
Approved Prior to Jan 1, 1982
FDA Approved
Discontinued
Status

FDA Application: 016755 ·

First Report: 20200101 · Latest Report: 20210605

What Are the Most Common LYPRESSIN Side Effects?

#1 Most Reported
Vomiting
51 reports (79.7%)
#2 Most Reported
Abdominal distension
51 reports (79.7%)
#3 Most Reported
Somnolence
50 reports (78.1%)

All LYPRESSIN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Abdominal distension 51 79.7% 51 42
Vomiting 51 79.7% 51 42
Abdominal pain 50 78.1% 50 41
Appendicitis 50 78.1% 50 41
Ascites 50 78.1% 50 41
Condition aggravated 50 78.1% 50 42
Hyponatraemia 50 78.1% 50 41
Off label use 50 78.1% 50 43
Sepsis 50 78.1% 50 41
Somnolence 50 78.1% 50 42
Appendicolith 49 76.6% 49 40
Cardiogenic shock 49 76.6% 49 40
Constipation 49 76.6% 49 40
Dry mouth 49 76.6% 49 41
General physical health deterioration 49 76.6% 49 40
Multiple organ dysfunction syndrome 49 76.6% 49 40
Nausea 49 76.6% 49 40
Stress 49 76.6% 49 40
Ventricular fibrillation 49 76.6% 49 41
Blood phosphorus increased 48 75.0% 48 40

Who Reports LYPRESSIN Side Effects? Age & Gender Data

Gender: 4.3% female, 95.7% male. Average age: 79.6 years. Most reports from: CA. View detailed demographics →

Is LYPRESSIN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2020 19 19 18
2021 2 2 1

View full timeline →

What Is LYPRESSIN Used For?

IndicationReports
Drug therapy 47
Product used for unknown indication 16

Official FDA Label for LYPRESSIN

Official prescribing information from the FDA-approved drug label.